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Optimal health and well-being are now considered the true measures of human development.
Integrated strategies for infant, child and adult nutrition are required that take a life-course
perspective to achieve life-long health. The major nutrition challenges faced today include: (a)
addressing the pending burden of undernutrition (low birth weight, severe wasting, stunting and
Zn, retinol, Fe, iodine and folic acid deficits) affecting those individuals living in conditions of
poverty and deprivation; (b) preventing nutrition-related chronic diseases (obesity, diabetes,
CVD, some forms of cancer and osteoporosis) that, except in sub-Saharan Africa, are the main
causes of death and disability globally. This challenge requires a life-course perspective as
effective prevention starts before conception and continues at each stage of life. While death is
unavoidable, premature death and disability can be postponed by providing the right amount
and quality of food and by maintaining an active life; (c) delaying or avoiding, via appropriate
nutrition and physical activity interventions, the functional declines associated with advancing
age. To help tackle these challenges, it is proposed that the term ‘malnutrition in all its forms’,
which encompasses the full spectrum of nutritional disorders, should be used to engender a
broader understanding of global nutrition problems. This term may prove particularly helpful
when interacting with policy makers and the public. Finally, a greater effort by the UN agen-
cies and private and public development partners is called for to strengthen local, regional and
international capacity to support the much needed change in policy and programme activities
focusing on all forms of malnutrition with a unified agenda.
Optimal health and well-being: Global nutrition challenges: Life-course perspective:
Integrated strategies for malnutrition
The health status of developing countries has long been
characterised by a predominance of endemic and epidemic
infectious diseases. In this context, undernutrition and
micronutrient deficiencies, which mostly affect children
and women of fertile age, are important as they aggravate
the severity and duration of infectious diseases(1). Under-
nutrition may also increase the incidence of some infec-
tions and may potentiate the virulence of some infectious
agents(2,3). The enormous scale of the estimated global
burden of death and disability currently associated with
undernutrition among children <5 years of age is shown in
Table 1. In contrast, industrialised countries are usually
characterised by their relative preponderance of disability
and death caused by non-communicable chronic diseases.
These latter diseases often result from changes in diet and
physical activity patterns induced by economic affluence
and from degenerative conditions linked to advanced
age(4). In these classic characterisations under- and over-
nutrition are presented as opposites ends of a spectrum and
contrasted against each another in terms of number of
deaths or disability-adjusted life years lost and their con-
tingent economic costs. This approach is overly simplistic,
which leads to competing research and policy agendas
and confusion; it detracts from the need to concentrate on
Abbreviation: NRCD, nutrition-related chronic diseases.
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solving the existing problems in which undernutrition and
nutrition-related chronic diseases (NRCD) are inter-
twined(5,6).
Epidemiological and nutrition transitions have now been
documented in most countries in the world making NRCD
the main cause of death and disability globally. These
transitions have resulted in increased life expectancy as a
result of a combination of falling neonatal deaths, in-
creased infant and child survival and extended longevity
of adults. The appearance of these transitions underscores
the need to see the effects of nutrition on health and well-
being as a continuum across the lifespan with multiple
interlocking consequences(7–9). As more of the population
reach older ages greater emphasis needs to be placed on
NRCD, many of which, to an important extent, originate in
early life. The prevention of diabetes, heart disease and
cancer was not considered as relevant in developing
countries until recently(10–12) as these diseases were con-
sidered to be diseases of affluence. However, both on an
absolute and age-adjusted basis these diseases are becom-
ing progressively more important in developing coun-
tries(10,13). The most common risk factors responsible for
global deaths according to the extent of socio-economic
development are summarised in Fig. 1. It is clear that most
nutrition-related risk factors for chronic disease are com-
mon in both developing and developed countries, perhaps
Table 1. Global deaths and disability-adjusted life years (DALY) in children <5 years of age in 2004, showing deaths and disability attributed to
micronutrient deficiencies and those attributed to nutritional (anthropometric) status (modified from Black et al.(1))
Deaths (n)
Percentage of
<5 years deaths
Disease burden
(·103 DALY)
Percentage of
<5 years DALY
Condition
Vitamin A deficiency 667 771 6.5 22668 5.3
Zn deficiency 453 207 4.4 16342 3.8
Fe deficiency 20854 0.2 2156 0.5
Iodine deficiency 3619 0.03 2614 0.6
Measure
Underweight* 1 957 530 19.0 81358 18.7
Stunting 1 491188 14.5 54912 12.6
Wasting* 1 505 236 14.6 64566 14.8
Severe wasting*† 449 160 4.4 25929 6.0
IUGR–low birth weight 337 047 3.3 13536 3.1
Total of stunting, severe wasting
and IUGR–low birth weight*‡
2 184 973 21.4 90962 21.2
IUGR, intrauterine growth restriction.
*Includes deaths (138 739) and DALY (14 486400) directly attributed to ‘protein–energy malnutrition’.
†Included in wasting.
‡Total takes into account the joint distribution of stunting and severe wasting.
Tobacco use
Cholesterol*
Underweight*
Unsafe sex
Fruit and vegetables*
High BMI*
Physical inactivity*
Alcohol*
Unsafe water, hygiene
Indoor smoke and fuels
Fe deficiency*
Urban air pollution
Zn deficiency*
Vitamin A deficiency*
Unsafe health and injections
0 1 2 3
Deaths (×106)
4 5 6 7 8
Blood pressure*
Fig. 1. Global deaths attributable to sixteen leading risk factors. (&) High mortality, devel-
oping countries; (K), low mortality, developing countries; ( ), developed countries;
*nutrition-related risks. (Modified from Uauy & Solomons(4).)
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with the only exception of underweight and specific nutri-
ent deficiencies. High prevalence of chronic conditions in
later life not only increases the burden of disease but will
also affect the allocation of financial resources, and thus
potentially undermine a country’s capacity to address
nutritional problems in early life.
In the face of this global scenario it is time to re-
examine the many faces of malnutrition and address them
with a common agenda that recognises the full spectrum of
nutrition-related death and disability. Before addressing
what are considered to be the key global challenges for
nutrition scientists a case will be made for the expansion of
the basic definition of malnutrition to one that encapsulates
malnutrition in all its forms.
Malnutrition in all its forms
In the new global nutrition environment it is clear that the
basic definition of malnutrition is not sufficient, and that
there is a need for a new definition that encompasses
underweight and overweight, wasting and stunting, micro-
nutrient deficiencies and NRCD. Underweight is defined
by a low weight-for-age, yet a child may be underweight
because she or he is wasted (low weight-for-height) or
stunted (low height-for-age) or both. Conversely, a child
may be stunted but overweight for his or her length. Within
the underweight category, wasted and stunted children
must be considered separately since they need to be
approached differently in their treatment and follow up.
The fact that among the undernourished as defined by
stunted linear growth there exist many who are of normal
weight for their length and some who are overweight for
their length(14) can no longer be ignored. Importantly, since
length is not systematically assessed in defining nutritional
status of populations(15) it is possible that the prevalence of
undernutrition may currently be overestimated and the
problem of excess body fat stores neglected. It follows
that if the aim is to tackle malnutrition in all its forms,
length must be systematically measured and assessed in all
children.
Acute wasting is an important form of malnutrition and
requires particular attention, especially within the context
of emergencies caused by famine (acute and chronic) and
conflict. Acute wasting is associated with child survival
since it has a direct impact on resistance to infection.
Effective treatment and control of acute wasting are
essential if hunger and mortality in children is to be
reduced in accordance with the internationally-agreed
Millennium Development Goals(16).
Micronutrient deficiencies also form part of the broader
definition of malnutrition. Poor quality of diets can lead to
inadequate intakes or deficiencies in one or more micro-
nutrients and, where possible, an attempt should be made
to determine the common underlying dietary causal fac-
tors. For example, epidemiological risk analysis indicates
that Fe and Zn deficiencies frequently occur together;
similarly, vitamin A deficit is observed in infants and
mothers subsisting on single staple foods (cereals or
tubers). Integrating findings in this manner, and examining
the need for changes in dietary patterns rather than
targeting individual nutrients, may provide more sustain-
able long-term solutions(9,17).
Finally, at the other end of the spectrum, any new defi-
nition of malnutrition must now also include NRCD. These
chronic diseases commonly presenting in adults are related
to long-term patterns of diet and physical activity. Pre-
vention for these conditions therefore starts with the
achievement of optimal fetal and infant growth and con-
tinues throughout the life course with the promotion of
healthy diets and active living(8). It must be remembered
that the pre-clinical conditions associated with ageing such
as loss of muscle and skeletal mass and loss of cognitive
functions are not obligatory states, and their impact may be
substantially attenuated by dietary, physical activity and
social interventions. The ultimate goal is what has been
termed the ‘compression of morbidity’(18), meaning that
ideally individuals should live the majority of their lives
free of the disabilities of acute and chronic illnesses and
impaired function, and extend their longevity towards the
upper limits of the human lifespan.
Reductionist approaches to nutrition have to date pro-
vided good service and important knowledge has been
gained on the effects of specific nutrients at the molecular,
cellular, organ and whole-body level. However, this
approach will not necessarily bring early provision of
coherent guidance to policy makers to achieve better
population health and well-being. If the gap between pre-
sent knowledge and population nutritional status and health
is to be bridged it will be necessary to use integrated
approaches to address malnutrition in all its forms with a
life-course perspective(19). Such approaches are also more
likely to attract the interest of the public and policy
makers, and thus effective action nationally and globally
will be brought closer. Agreeing on a definition of mal-
nutrition in all its forms will encourage more widespread
usage and hopefully contribute to developing a common
agenda for action.
Global nutrition challenge 1: addressing the
pending burden of undernutrition and
micronutrient deficits
Undernutrition, as assessed by abnormal anthropometric
measures, and micronutrient deficiencies are frequently
interrelated. For example, the disease outcome diarrhoea is
associated with vitamin A and Zn deficiencies as well as
stunting. In contrast, certain micronutrient deficiencies
such as iodine and Fe may occur in children with normal
somatic growth, which is further complicated by the fact
that the consequences of certain micronutrient deficiencies
may in fact be dependent on their effects on growth. For
example, approximately half the effect of Zn deficiency is
mediated by stunting; the rest is a direct effect on mor-
bidity and mortality, probably as a result of impaired
immune function(1). Analyses of the population attri-
butable risk of malnutrition should therefore consider the
effects of not only single but also combined micronutrient
deficits together with other measures of malnutrition such
as somatic growth.
36 R. Uauy et al.
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
While the risks related to suboptimal breast-feeding
(optimal breast-feeding based on WHO recommenda-
tions(20) is exclusive breast-feeding from birth to 6 months
of life and continued breast-feeding complemented with
appropriate micronutrient dense foods after 6 months) may
in part be associated with micronutrient deficiencies
resulting from inadequate dietary intake by the infant, they
are more importantly a result of the role of breast milk in
preventing infections. The disease burden attributed to
suboptimal breast-feeding cannot be added to that of
undernutrition without considering their joint effects;
however, it is nonetheless appropriate to consider breast-
feeding practices as one of the most important modifiable
risk factors for infectious disease in infants. Effective
interventions are also available to reduce stunting, micro-
nutrient deficiencies and child deaths. If implemented at
scale, they would reduce disability-adjusted life years and
child deaths by about one-quarter in the short term(16,21,22).
Systematic reviews of available evidence on the effec-
tiveness of interventions published in the Lancet series on
maternal and child undernutrition indicate that breast-
feeding counselling and vitamin A and Zn fortification or
supplementation have the greatest potential to reduce the
burden of child morbidity and mortality(21). The reviews
also suggest that enhancing complementary feeding via
nutrition counselling for food-secure populations and
nutrition counselling, food supplements and/or conditional
cash transfers in food-insecure populations could also
substantially reduce stunting in the short term. Elimination
of stunting, however, will require long-term investments to
improve education, economic status and empowerment of
women. The evidence base in the systematic reviews for
maternal health is weaker, but there is some evidence that
nutrition interventions such as Fe and folate supplements
and targeted balanced energy and protein supplementation
may make a difference to maternal health and birth out-
comes. Collectively, the anthropometric and micronutrient
deficiencies examined in the recent Lancet series on
maternal and child undernutrition accounted for approxi-
mately 30% of total deaths and disease burden in children
<5 years of age, which equates to approximately 9% of
the total global disease burden in all ages(1). This enor-
mous pending burden highlights the need for immediate
and concerted efforts to implement known effective
actions.
Global nutrition challenge 2: prevention of
diet-related chronic disease with a life-course
perspective
The excessive segmentation and specialisation of human
nutrition into energy, macronutrients and micronutrients
and of clinical sciences into newborn medicine, paedia-
trics, adolescent health, adult health and geriatrics has been
a barrier to integrating the various stages of development
in human health(23). A common denominator for an in-
tegrated view is a systematic ‘life-course’ approach(8). A
complex but compelling and highly-relevant relationship
(schematically presented in Fig. 2) has been revealed
between the processes of undernutrition and poor growth in
fetal life or early infancy and metabolic and malignant
disease consequences in adult life(19,24).
The epidemiology of the early origins of adult dis-
ease(25) and the concept of early-life programming based
on a persistence of a nutrient-conserving metabolic pattern
throughout the lifespan, emphasise health over disease in
the relationship of nutrition, early growth, metabolic
imprinting and vulnerability to chronic disease(26). The
postulate of the ‘developmental origins of health and dis-
ease’ hypothesis is that the early environment programmes
metabolism, organ growth and functional development in
an irreversible manner even after the original deprivation
has been resolved. Programming may be explained by
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Fig. 2. Life-course approach to prevention of chronic disease in adult life. (L), The
critical steps to achieve healthy growth and long-term health; (K), the end points that
define increased risk. High BMI and metabolic syndrome interact in defining risk for
chronic disease in adult life.
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structural changes in organs induced during early devel-
opment, or by epigenetic modifications that permanently
modify the patterns of gene expression, which in turn
affect organ function at later stages in the life course.
These changes are associated with permanent changes in
physiology and/or structure that will predispose individuals
to obesity and other NRCD in later life.
The relationship between low birth weight and later
occurrence of central obesity, insulin resistance, type 2
diabetes, hypertension and CVD has been documented in a
number of epidemiological studies conducted mostly in
industrialised countries(27–29), and in follow-up studies of
historic cohorts from transitional countries(30). In most
developing regions low birth weight, and underweight and
stunting in young children, coexists with overweight and
obesity in older children, adolescents and the adult popu-
lation(31,32). Thus, the ‘developmental origins of health and
disease’ hypothesis may be most relevant to present and
future public health in these countries.
Analyses of the five existing cohort studies from devel-
oping countries (India, Guatemala, South Africa, Brazil
and the Philippines) have recently been reported(30). These
cohorts were established in 1975–90 and with some inter-
ruptions subjects have been followed to the present. In
India, Guatemala and Brazil birth weight was found to be
positively associated with BMI at age 25–30 years, yet
with a stronger association for lean mass than for fat mass.
The links between birth weight and later occurrence of
NRCD have proven more difficult to elucidate and the
results are not fully consistent across studies. However, the
studies differ widely in the extent of early malnutrition, the
presence and extent of recovery of growth and of acceler-
ated growth at various life stages and in the final nutri-
tional status in terms of residual stunting, underweight and/
or overweight. These factors are likely to be responsible
for the observed differences in outcomes across studies. In
the case of subjects from south and south-east India the
susceptibility to insulin resistance and cardiovascular risks
is even higher than in the population from other developing
countries. This finding is explained by their particular
malnutrition phenotype, in which low-birth-weight babies
have increased visceral adiposity and insulin resistance
even before overweight and obesity can be established
based on current Western criteria(33,34).
The other maladaptive nutritional situation of fetal life
with an adverse prognosis for long-term health is macro-
somia (birth weight of >4000 g). This excessive intrauter-
ine growth is a result of excess fuel availability leading to
higher insulin levels, generally as the result of gestational
hyperglycaemia in the mothers(35). Cohort studies of
infants who are macrosomic have shown that high birth
weight and overweight in infancy is also a risk factor for
diabetes in later life(36,37).
The importance of the existence and timing of a period
of rapid childhood growth in potentiating the relationship
between fetal undernutrition and later chronic disease is a
matter of current debate(38,39), partly because of the recent
changes in the environment in terms of progressive in-
creased prevalence of risk factors for obesity as opposed
to the subtle effects observed in the older historic cohorts.
A systematic review has identified sixteen studies that have
presented data on the role of rapid childhood growth as a
possible determinant of obesity in adulthood, thirteen of
which have reported significant associations, although the
lack of standardisation between studies is also noted,
making interpretation difficult(40). The extent to which
rapid infant growth represents a risk may depend on whe-
ther it occurs in the context of recovery from fetal growth
restriction and results in normalisation of body weight and
length, or whether excess growth is predominantly pond-
eral with constrained linear gain, thus leading to excess
weight for length(29,41).
The age of the adiposity rebound (age at which the BMI
increases after its childhood nadir) is another period in
which childhood growth seems to be critical for later
life(42). On average this BMI increase normally happens
between 5 and 7 years of age, an earlier adiposity rebound
is associated with increased fatness later in life(43). This
relationship is illustrated by the fact that adults whose
adiposity rebound occurred by 4.8 years of age have a six
times higher risk of being obese (BMI>27 kg/m2) than
those who had their adiposity rebound after 6.2 years of
age(44). Similar adverse consequences of early adiposity
rebound have been reported for risks of glucose intoler-
ance, diabetes and hypertension(45–47). However, there is
some uncertainty as to whether the negative effect of an
early adiposity rebound is independent of early-life BMI or
BMI percentile crossing(48,49).
Recently, it has been proposed that, at least in women,
puberty may correspond to a critical period for the devel-
opment of certain cancers(50). In a cohort of women born
in Finland during the early 1930s women whose mothers
had larger pelvic diameters (iliac crests) had a higher
risk of breast and ovarian cancer, especially if those
mothers also had an early menarche. The authors have
proposed that the larger diameters of the pelvic bones
may result from a higher exposure to oestrogens during
puberty, an effect that may persist throughout life and
might impact on cell differentiation of breast and ovarian
tissue of female fetuses while in utero. They conclude that
the maternal sex-hormone profile that initiates ovarian and
breast cancer may be the product of poor nutrition
and growth in early childhood followed by catch-up pre-
pubertal growth.
Overall, there is good evidence that growth trajectory is
relevant in the aetiology of later chronic disease(51). Whe-
ther the sequence is underweight-to-overweight or over-
weight-to-overweight, the consequence of malnutrition in
early life is an increased risk of the burden of chronic
disease during adolescence and adulthood. This outcome
creates a second burden in societies simultaneously dis-
posed to high rates of poor fetal growth, and supports the
need to have appropriate definitions of malnutrition and
carefully-designed research on the life-course con-
sequences of early growth patterns. This research can serve
as a framework to uncover the most effective measures to
promote individual and public health in order to reduce
future morbidity and disability. Such an approach will not
only lead to better health and wellbeing, but ultimately
may halt the progression of the escalating economic costs
of malnutrition to beyond a level that society can afford to
provide in an equitable manner.
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Global nutrition challenge 3: nutrition for
optimal health and well-being across the lifespan
(healthy ageing)
Increased longevity in human subjects must surely rank as
one of the great biosocial and biomedical triumphs of the
modern era. Declining fertility together with increased
longevity has meant that all countries are experiencing
growth in the absolute number, and in many countries also
in the proportion, of older individuals in the population.
UN estimates project that by the year 2050 individuals
aged ‡ 60 years will represent 22% of the world’s popu-
lation, or about two billion individuals (a rise from 10% or
600 million individuals in 2000)(52). Of particular impor-
tance is the growth in the population of the proportion of
the oldest old. The world’s population of individuals aged
‡80 years is projected to more than triple in the period
2000–50, from 1.2% (73 million individuals) to 4.3%
(400 million individuals)(52). However, while increased
longevity is a triumph, it is also likely to be one of the
great global challenges for human health(53).
With the growing size of the cohort of older individuals,
identifying interventions that promote good health in later
life becomes increasingly desirable, especially in countries
with limited resources to devote to the care of older indi-
viduals in poor health. The Madrid International Plan of
Action on Ageing provides a framework for the multi-
sectoral efforts that are needed to encourage active and
healthy ageing(54). This Plan of Action on Ageing empha-
sises the importance of adequate nutrition throughout the
life course and of national food policies that recognise
older individuals as potentially vulnerable. Global pertur-
bations in food costs, especially of staple crops such as rice
and wheat, are also likely to have a dramatic effects on
food security(55).
Compared with research commitments and policy
initiatives in younger age-groups, national-level actions
designed to have an impact on the nutrition and health of
older individuals have been limited until relatively
recently. This situation may be the result of a variety of
factors, such as negative images of ageing, concepts that
health promotion and disease prevention in old age are not
worthwhile and the research community’s relative neglect
of many of the common problems of old age. The reality of
demographic change should force a reconsideration of
many of these factors and it is becoming clear that a mul-
tidisciplinary national level approach is required that fully
integrates population ageing and the needs of older indi-
viduals into all areas of public policy, including health,
housing, economic development and transport.
The government of Chile provides a good example of a
national-level nutrition intervention aimed at promoting
healthy ageing and preserving health and function in later
life. The Programme of Complementary Feeding for the
Older Population is a package of actions which, since
1998, has been providing micronutrient-fortified foods to
individuals aged ‡70 years registered at Primary Health
Centres. The recommended serving size (50 g/d) of these
fortified foods provides 50% of the daily micronutrient
requirements and 20% of the daily energy requirements
of older individuals(56). In collaboration with the Ministry
of Health in Chile, a cluster randomised trial is currently
being conducted in Santiago to determine the cost-
effectiveness of the Programme of Complementary Feed-
ing for the Older Population and a specially-designed
resistance training exercise class for older individuals(57),
which could serve as blueprints for similar interventions in
other nations.
In order to reflect on the level of the UK government’s
actions in social and health policy to support older indivi-
duals, the cost of healthy living for older individuals in
England has recently been estimated(58). Using conclusions
of expert reviews and published research, the best evidence
on the needs for healthy living for individuals aged ‡ 65
years (without major disability) in England, was derived
for nutrition, physical activity, housing, psychosocial rela-
tions and social inclusion, mobility, medical care and
hygiene. This knowledge was translated into presumptively
acceptable ways of living, and the corresponding minimal
personal costs were assessed from low-cost retailers or,
where unavoidable, from national data on the expenditure
of low-income older individuals. The minimum income
requirements for healthy living for this population in
England were found to be 50% greater than the state pen-
sion, and even appreciably greater than the official mini-
mum income safety level. The results suggest that
inadequate income currently could be a barrier to healthy
living for older individuals in England. In 2007 the cost of
the defined healthy diet represented 25% of the total
weekly budget for older individuals. Increasing food costs,
without concomitant increases in social support, is likely to
create further strains on household budgets and may also
affect food security for older individuals.
It is evident, however, that there is tremendous variation
between individuals in the extent of age-related changes in
health and function. This disparity has led some research-
ers to propose a distinction between ‘usual’ and ‘suc-
cessful’ ageing, or ageing well(59). While there is a
growing body of evidence to support the role of genetic
constitution in some aspects of healthy ageing, such as risk
of Alzheimer’s disease(60) and age-related macular degen-
eration(61) and physiological responses to exercise(62), it is
also clear that nutrition and lifestyle factors across the life
course are crucially important. For example, in a pan-
European study adherence to four healthy lifestyle charac-
teristics, i.e. consumption of a Mediterranean-style diet,
moderate alcohol intake, regular physical activity and not
smoking, was shown to increase the chance of survival
over 10 years by >50%(63). Such a regimen can be pro-
moted by public health nutrition professionals and does not
depend on access to high-tech medical care or large
financial resources.
Interestingly, a recent Finnish cohort study has shown
that maintenance of healthy public health nutrition vari-
ables (healthy body weight, low cholesterol, low blood
pressure and regular physical activity) are also associated
with lower risk of incident dementia(64). This finding
highlights the possible role of nutrition in the prevention of
cognitive decline and dementia, a role first proposed 25
years ago(65). The number of individuals with age-related
cognitive impairment is rising dramatically in the UK(66)
and globally(67), and the prevention and treatment of
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dementia is one of the major global challenges for health in
which nutrition may have an important role to play.
A mass of epidemiological evidence linking nutrient
supplementation to cognitive function and dementia has
been published over the past 25 years, but unfortunately it
has largely not been corroborated by the clinical trials that
have been conducted in older individuals. Indeed, a series
of Cochrane and other systematic reviews have concluded
that there is no evidence of an effect of supplementation
with various B-vitamins(68,69) or vitamin E(70) on cognitive
health in later life. However, two sets of candidate nutri-
ents, the B-vitamins and the n-3 long-chain PUFA, remain
influential on the nutrition and cognitive function research
agenda(71).
High levels of homocysteine are a known risk factor for
vascular disease in mid-life(72) and older age(73), and
interestingly have also been shown to be associated with
cognitive function in later life(74). A small clinical trial that
randomised 276 individuals aged ‡ 65 years at baseline to
receive either a daily supplement containing 1000mg
folate, 500mg vitamin B12 and 10 mg vitamin B6 or a
placebo for 2 years has demonstrated marked reductions in
homocysteine in the intervention group, but no difference
between trial arms in cognitive function at the end of the
intervention(75). However, the recent publication of a larger
clinical trial(76) that randomised 818 individuals aged 50–
70 years at baseline to receive either 800mg folic acid or
placebo daily for 3 years has revitalised the hypothesis.
The intervention was found to result in a 26% decrease in
homocysteine levels, and the authors reported a beneficial
effect of folic acid supplementation on three of the five
cognitive domains under investigation. As background
work for an ongoing trial investigating the effect of
vitamin B12 supplementation on central and peripheral
nerve function and cognitive health (the Older People and
Enhanced Neurocognitive function Study), an analysis of
individual participant data from the available published
clinical trials investigating B-vitamin supplementation and
cognitive function is currently being undertaken, which
will hopefully provide more information on the potential
role of these nutrients in cognitive health in later life.
Epidemiological evidence for an association between
n-3 long-chain PUFA consumption and cognitive function
is similarly intriguing. A systematic review has identified
four cohort studies reporting associations between n-3
long-chain PUFA and cognitive health(77). All four studies
have suggested a positive impact of increased n-3 long-
chain PUFA consumption (either as fish or as total n-3
long-chain PUFA) on risk of impaired cognitive function
or incidence of dementia. More recently, follow up of 210
surviving males in the Zutphen Elderly Study has demon-
strated that among men aged 70–89 years at baseline fish
consumption is associated with a slower rate of cognitive
decline over 5 years(78). Finally, follow up of 899 men and
women in the Framingham Heart Study with a mean age of
76 years at baseline has demonstrated that individuals with
the highest levels of plasma phosphatidylcholine-DHA
have a decreased risk of incident dementia over 9 years(79).
While the case for n-3 long-chain PUFA in healthy
cognitive ageing is building, a Cochrane review has found
no published randomised controlled trials investigating the
effect of n-3 long-chain PUFA supplementation on cogni-
tive function among healthy older adults(80). One recent
clinical trial randomised 174 participants with mild-to-
moderate Alzheimer’s disease and a mean age of 74 years
to receive either 2.3 g n-3 long-chain PUFA or placebo
daily for 6 months(81). No difference was found in the rate
of decline in cognitive function between the study groups
at the end of the 6-month intervention, but in a subgroup of
thirty-two participants with very mild cognitive function
loss at baseline the rate of cognitive decline in the inter-
vention arm was found to be slower than that in the
placebo arm. While these results are exciting, they must be
confirmed by larger studies. A randomised controlled trial,
the Older People And n-3 Long chain polyunsaturated fatty
acid Study(82), is currently investigating the effect of 0.7 g
n-3 long-chain PUFA supplementation daily (which equates
to about two portions of oily fish per week) for 2 years on
a cohort of >860 healthy adults aged 70–79 years at
baseline. The results of the trial are due in early 2009. To
meet the global challenge of ageing, considerably greater
attention is clearly needed to help define cost-effective
public health nutrition interventions to maintain health and
function in later life.
Conclusions
The following conclusions are proposed in order to meet
the global nutrition challenges for optimal human health
and well-being in the new millennium:
1. agree to use the term ‘malnutrition in all its forms’ as
a description that encompasses the full spectrum of
nutritional disorders when interacting with policy
makers and members of the public;
2. develop integrated prevention and control strategies
for infant, child and adult undernutrition, and nutri-
tion-related chronic disease throughout the life course;
3. reconsider the concept of dietary quality and optimal
growth beyond immediate survival, particularly in
relation to life-long health. There remains a critical
need to define what is meant in practice by ‘adequate
food’, considering not only quantity of energy but also
overall diet quality;
4. address optimal nutrition for healthy aging based on
emerging evidence of the impact of nutrition and
physical activity interventions on age-related func-
tional and health decline;
5. call for a greater effort by the UN agencies, private
and public development partners and other organisa-
tions to develop and/or strengthen local, regional and
international leadership capacity to support the much-
needed change in policy and programme activities,
focusing on malnutrition in all its forms with a unified
agenda.
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